Načítá se...
Treatment response with mepolizumab in severe eosinophilic asthma patients with previous omalizumab treatment
BACKGROUND: We performed post hoc analyses to evaluate the effect of humanized monoclonal antibody mepolizumab in patients with severe eosinophilic asthma previously treated with omalizumab. METHODS: Data were collected from two randomized double‐blind, placebo‐controlled studies: MENSA (NCT01691521...
Uloženo v:
| Vydáno v: | Allergy |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5089585/ https://ncbi.nlm.nih.gov/pubmed/27087007 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/all.12914 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|